coronavirus vaccine
Covid-19: Government orders 66 crore vaccine doses worth RS 14,505 crore
The government is placing its largest order yet of Covid vaccines at 66 crore doses worth Rs 14,505 crore to procure Covishield and Covaxin shots that will help it to substantially meet the vaccine availability projections it had made in the Supreme Court, reports Times of India.
The order is in line with the Centre's estimate of 135 crore doses being available between August-December as stated in its affidavit submitted to the Supreme Court on June 26. Apart from the order for 66 crore doses, the government has made an advance payment to reserve 30 crore doses of Hyderabad based Biological-E's Corbevax vaccine, official sources said.
Read:India's human rights body favours federal probe into Bengal post-poll violence
Coronavirus live updates
This means a total of 96 crore doses are expected to be available on account of government procurement during August December. While the 96 crore doses comprises Centre's share of 75% of the total manufactured doses, the private sector will also have another 22 crore doses of Covishield and Covaxin available during the period.
The order and other anticipated supplies, said officials, will help India remain on track to ensure vaccination for the 18+plus population by the year-end.
The total production of Covishield and Covaxin in August-December is placed at 88 crore doses. Despite a shortfall of around 3.5 crore doses in July, Covaxin production is put at 38 crore in this period, slightly less than the 40 crore mentioned in the SC affidavit. The glitches in its production are understood to have been sorted out.
Read:Nepal, India sign deal for $1.3 billion Lower Arun Hydropower project
Apart from Covishield, Covaxin and Corbevax, the government's estimate of 135 crore doses also included Sputnik V and Zydus Cadila's vaccine. While Sputnik V locally manufactured supplies are yet to start, Cadila's approval is pending. Ten crore Sputnik and five crore Cadila are estimated to be available this year, according to the Centre's affidavit.
"Government has already made an advance payment 96 doses and another 22 crore doses will be available for the private sector, thus securing a large bulk of the expected supply well in advance," said an official source.
The order assumes significance as it assures a supply of jabs to ensure ramping up of vaccination drive amid fear of a third wave. The government aims to inoculate the entire adult population above 18 years age by December. A total of 39.49 crore doses have been administered across the country till Thursday 7pm.
Read: Sputnik V's commercial roll-out in India in coming weeks: Dr Reddy's Laboratories
The Centre has indicated availability of 13.5 crore doses during July, which would translate into an average 50 lakh doses per day. While daily vaccinations have been modest in July so far with a little over 5 crore doses given so far in the month, the states have been asked to ramp up sessions along with that in the private sector where pick up has been slow so far.
While some states have raised concerns about irregular supplies of jabs, the health ministry has emphasised on advance planning and logistics management to ensure that neither people are turned away nor doses are wasted. The health ministry indicates availability of doses to states 15 days in advance to enable planning of vaccination centres and sessions accordingly.
China to continue providing vaccine aid to Bangladesh: Wang Yi
Chinese Foreign Minister Wang Yi has said China will continue to provide Bangladesh with Covid-19 vaccines to help the country fight the pandemic.
He also said China is willing to work with Bangladesh to maintain the momentum of the development of the strategic cooperative partnership between the two countries.
Read: With IVI's help, Bangladesh hopeful of domestic vaccine production
The Chinese State Councilor and Foreign Minister met Foreign Minister Dr AK Abdul Momon in Tashkent and discussed the issues on the sidelines of the International Conference on “Central and South Asia: Regional connectivity - Challenges and opportunities” inTashkent, Uzbekistan on Thursday.
Wang Yi said that China and Bangladesh are good neighbors and friends and the two sides always adhere to equal treatment and mutual respect, continue to deepen friendly cooperation, and actively jointly build the "Belt and Road".
Yi said China highly appreciates Bangladesh’s firm support for China’s correct position on issues related to China’s core interests, and will, as always, support Bangladesh in safeguarding national sovereignty, independence and territorial integrity, safeguarding international fairness and justice, and upholding the basic norm of international relations of non-interference in internal affairs.
"Both parties must jointly oppose the politicization of the virus's origin. China is willing to provide support and assistance to Bangladesh in poverty reduction through China and South Asian Poverty Reduction Centers," said the Chinese Foreign Minister.
Read:Vaccine institute in Bangladesh can be a gamechanger for its economy: Experts
Dr Momen said that Bangladesh has always adhered to the one-China principle and firmly supports China on issues involving China's internal affairs such as Xinjiang, Hong Kong, and Tibet.
"Thanks to China for providing vaccine assistance to Bangladesh and sending charcoal in the snow at a critical moment," he said.
Bangladesh opposes the politicization of traceability, and hopes to cooperate with China in vaccine filling, and strengthen anti-epidemic cooperation under the framework of the six countries of Bangladesh and China's Abanis, said a media release shared by the Chinese Embassy in Dhaka.
"China has set an example for the world in poverty reduction. Bangladesh supports the China and South Asian Poverty Reduction Centers proposed by China and hopes to share China’s experience in poverty reduction," it reads.
Read: Dhaka thanks Beijing for vaccine supply during difficult time
Bangladesh hoped that China will continue to play a mediating and constructive role in properly resolving the Rakhine State issue.
Dr Momen reiterated his request to initiate vaccine coproduction in Bangladesh with partnership from Bangladeshi and Chinese stakeholders.
Vaccine deliveries rising as delta virus variant slams Asia
As many Asian countries battle their worst surge of COVID-19 infections, the slow-flow of vaccine doses from around the world is finally picking up speed, giving hope that low inoculation rates can increase and help blunt the effect of the rapidly spreading delta variant.
With many vaccine pledges still unfulfilled and the rates of infection spiking across multiple countries, however, experts say more needs to be done to help nations struggling with the overflow of patients and shortages of oxygen and other critical supplies.
Some 1.5 million doses of the Moderna vaccine were set to arrive Thursday afternoon in Indonesia, which has become a dominant hot spot with a record high infections and deaths.
The U.S. shipment comes in addition to 3 million other American doses that arrived Sunday, and 11.7 million doses of AstraZeneca that have come in batches since March through the U.N.-backed COVAX mechanism, the last earlier this week.
Read:Immunized but banned: EU says not all COVID vaccines equal
“It’s quite encouraging,” said Sowmya Kadandale, health chief in Indonesia of UNICEF, which is in charge of the distribution of vaccines provided through COVAX. “It seems now to be, and not just in Indonesia, a race between the vaccines and the variants, and I hope we win that race.”
Many, including the World Health Organization, have been critical of the vaccine inequalities in the world, pointing out that many wealthy nations have more than half of their populations at least partially vaccinated, while the vast majority of people in lower-income countries are still waiting on a first dose.
The International Red Cross warned this week of a “widening global vaccine divide” and said wealthy countries needed to increase the pace of following through on their pledges.
“It’s a shame it didn’t happen earlier and can’t happen faster,” Alexander Matheou, the Asia-Pacific director of the Red Cross, said of the recent uptick in deliveries. “There’s no such thing as too late — vaccinating people is always worth doing — but the later the vaccines come, the more people will die.”
Vietnam, Thailand and South Korea have all imposed new lockdown restrictions over the past week as they struggle to contain rapidly rising infections amid sluggish vaccination campaigns.
In South Korea — widely praised for its initial response to the pandemic that included extensive testing and contact tracing — a shortage in vaccines has left 70% of the population still waiting for their first shot. Thailand, which only started its mass vaccination in early June, is seeing skyrocketing cases and record deaths, and only about 15% of people have had at least one shot. In Vietnam, only about 4% have.
“Parts of the world ... are talking about reclaiming lost freedoms such as going back to work, opening the cinemas and restaurants,” Matheou told The Associated Press. “This part of the world is far away from that.”
Indonesia started aggressively vaccinating earlier than many in the region, negotiating bilaterally with China for the Sinovac jabs. Now about 14% of its population — the fourth largest in the world — has at least one dose of a vaccine, primarily Sinovac. Several countries also have their own production capabilities, including South Korea, Japan and Thailand, but still need more doses to fill the needs of the region’s huge population.
“Both Moderna and AstraZeneca have been really critical in ramping up these numbers and ensuring that the supplies are available,” said UNICEF’s Kadandale, noting that Indonesia plans to have some additional 208.2 million people vaccinated by year’s end and is giving 1 million shots daily. “Every single dose does make a huge difference.”
Many other countries in the region have vaccination rates far below Indonesia’s for a variety of reasons, including production and distribution issues as well as an initial wait-and-see attitude from many early on when numbers were low and there was less of a sense of urgency.
Some were shocked into action after witnessing the devastation in India in April and May as the country’s health system collapsed under a severe spike in cases that caught the government unprepared and led to mass fatalities.
At the same time, India — a major regional producer of vaccines — stopped exporting doses so that it could focus on its own suffering population.
Read:FDA adds warning about rare reaction to J&J COVID-19 vaccine
The U.S. has sent tens of millions of vaccine doses to multiple countries in Asia recently, part of President Joe Biden’s pledge to provide 80 million doses, including Vietnam, Laos, South Korea and Bangladesh. The U.S. plans to donate an additional 500 million vaccines globally in the next year, and 200 million by the end of 2021.
“Indonesia is a critical partner for U.S. engagement in Southeast Asia and the vaccines come without strings attached,” said Scott Hartmann, a spokesman for the U.S. Embassy in Jakarta. “We’re doing this with the object of saving lives and ending the global pandemic, and equitable global access to safe and effective vaccines is essential.”
Earlier in the week, German Foreign Minister Heiko Maas, whose country is one of the largest financial backers of COVAX, accused Russia and China of using their delivery of vaccines for policy leverage.
“We note, in particular with China, that the supply of vaccines was also used to make very clear political demands of various countries,” he said, without providing specific examples.
There are also growing questions about the effectiveness of China’s Sinovac vaccine against the delta variant of the virus.
Thai officials said that booster doses of AstraZeneca would be given to front-line medical personnel who earlier received two doses of Sinovac, after a nurse who received two doses of Sinovac died Saturday after contracting COVID-19.
Sinovac has been authorized by WHO for emergency use but Indonesia also said it was planning boosters for health workers, using some of the newly delivered Moderna doses, after reports that some of the health workers who had died since June had been fully vaccinated with the Chinese shot.
“We have still found people getting severe symptoms or dying even when they are vaccinated,” Pandu Riono, an epidemiologist with the University of Indonesia, said about the Sinovac shot. “It’s only proven that some vaccines are strong enough to face the delta variant — AstraZeneca, Moderna and Pfizer seem capable.”
While the majority of recent deliveries have been American, Japan was sending 1 million doses of AstraZeneca on Thursday each to Indonesia, Taiwan and Vietnam as part of bilateral deals, and Vietnam said it was receiving 1.5 million more AstraZeneca doses from Australia.
The Philippines is expecting a total of 16 million doses in July, including 3.2 million from the U.S. later this week, 1.1 million from Japan, 132,000 of Sputnik V from Russia, as well as others through COVAX.
Japan is also is sending 11 million through COVAX this month to Bangladesh, Cambodia, Iran, Laos, Nepal, Sri Lanka, and others. Canada this week committed an additional 17.7 million surplus doses to the 100 million already pledged through COVAX, which is coordinated by Gavi, a vaccine alliance.
In addition to distributing some donated vaccines, financial contributions to COVAX also help fund the purchase of doses to distribute for free to 92 low or moderate income nations.
Read: Pfizer to discuss vaccine booster with US officials Monday
Earlier this month, it took blistering criticism from the African Union for how long it was taking for vaccines to reach the continent, which noted that just 1% of Africans are fully vaccinated.
Gavi said the vaccine shortfall so far this year is because the major COVAX supplier, the Serum Institute of India, diverted production for domestic use.
In its latest supply forecast, however, Gavi shows deliveries just beginning a sharp uptick, and still on track to meet the goal of about 1.5 billion doses by year’s end, representing 23% coverage in lower and middle income nations, and more than 5 billion doses by the end of 2022.
“It’s better to focus on vaccinating the world and to avoid hoarding doses,” said Matheou, of the Red Cross. “Sharing vaccines makes everyone safer.”
FM leaves for Tashkent to join global conf on South, Central Asia connectivity
Foreign Minister Dr AK Abdul Momen left Dhaka on Wednesday for Tashkent, Uzbekistan to attend an international conference titled “Central and South Asia: Regional Connectivity - Challenges and Opportunities” which begins on Thursday.
Dr Momen will hold a meeting with the President of Uzbekistan Shavkat Mirziyoyev during his stay there.
“I’ll thank the President of Uzbekistan on behalf of Prime Minister Sheikh Hasina," said the Foreign Minister.
Read:Nothing to be sceptical about Chinese vaccines: FM
He said he will also hold a number of bilateral meetings on the sidelines of the conference, including meetings with Indian External Affairs Minister Dr Jaishankar, Chinese Foreign Minister Wang Yi and Russian Foreign Minister Sergey Lavrov.
Dr Momen said he will discuss vaccine and Rohingya issues during his engagements in Tashkent. “Repatriation of Rohingyas remains our number one priority. We’ll seek additional efforts.”
He said China will give 10 lakh doses of Sinopharm vaccine as a gift to Bangladesh and he will discuss vaccine issues during his meeting with the Chinese Foreign Minister. “This is also very good news.”
Dr Momen said Bangladesh is a leader in terms of seeking wider connectivity and he will discuss with the Civil Aviation Minister of Uzbekistan to introduce direct Dhaka-Tashkent flight.
President of Uzbekistan Shavkat Mirziyoyev is hosting the two-day global forum to strengthen regional connectivity in the context of the new open foreign policy strategy of Tashkent.
The idea is aimed at further deepening economic cooperation in Central Asia, with access to South Asia, which has historically been closely linked to this region in economic, social, cultural and civilizational dimensions.
Read: FM to join global conf on South, Central Asia connectivity in Tashkent
French rush to get vaccinated after president’s warning
More than 1 million people in France made vaccine appointments in less than a day, according to figures released Tuesday, after the president cranked up pressure on everyone to get vaccinated to save the summer vacation season and the French economy.
Some bristled at President Emmanuel Macron’s admonition to “get vaccinated!” immediately, but many people signed up for shots, accepting that getting injected was the only way to return to some semblance of pre-pandemic life.
French government spokesman Gabriel Attal, noting the latest virus surges from South Africa to South Korea, and vaccine shortages in many poorer countries, appealed to his compatriots Tuesday to “look at what’s happening in the world.”
Read:Malaysia shuts vaccination center after 204 staff infected
Macron also announced that special COVID-19 passes will be required starting in early August to enter restaurants and shopping malls and to get on trains and planes. The announcement raised questions and worries among foreign tourists and as residents of France planning vacations.
An app that centralizes France’s vaccine appointments, Doctolib, said Tuesday that 1.3 million people signed up for injections after Macron gave a televised address Monday night. It was a daily record since France rolled out coronavirus vaccines in December. People under age 35 made up most of the new appointments, Doctolib said.
Macron said vaccination would be obligatory for all health care workers by Sept. 15, and he held out the possibility of extending the requirement to others. Around 41% of the French population has been fully vaccinated, though the pace of shots being delivered has waned as summer vacations approached.
Government spokesman Attal insisted the vaccine mandate wasn’t meant to “stigmatize” reluctant health workers but to limit risks to the vulnerable populations they care for.
Some residents said the government’s vaccine push makes them feel safer. At a vaccine center Tuesday in Versailles, finance worker Thibault Razafinarivo, 26, said, “I have a newborn baby at home, and we don’t want to take any risks.” A 23-year-old who works in radiology said she wants to protect her family and her patients.
Read:Death toll rises to 92 in blaze at coronavirus ward in Iraq
Others, though, expressed frustration at the idea of mandatory vaccines or needing passes to go to a café.
“I’m getting vaccinated because I want to have a social life and go on holidays,” law student Marius Chavenon, 22, said, adding: “I don’t think vaccination should be compulsory. We live in France, we should be able to do what we want.”
In Paris, nurse Solene Manable said, “There are many health workers who don’t want to get vaccinated because we don’t know much about the vaccines.” But she said she understood “many people who are getting vaccinated to be able to go back to restaurants,...to be able to have a normal life again.”
Some people said they’re now getting vaccinated because Macron also announced that France will start charging money for some virus tests, which up to now have all been free for anyone in French territory.
To get the COVID pass that will soon be required in all restaurants, people must have proof of vaccination or recent virus infection, or a negative test from the last 48 hours.
Read:US COVID-19 cases rising again, doubling over three weeks
Restaurant and bar unions demanded a delay for the passes, and government officials were meeting with industry representatives Tuesday. Restaurant workers expressed concern with enforcing the requirement and fear it could scare customers away after all French eating establishments stayed shuttered for nine months from the pandemic’s onset.
Health Minister Olivier Veran defended the new rule, saying, “The question is: It’s lockdown or the health pass.”
He also welcomed the renewed vaccine interest, saying on BFM television Tuesday: “That’s thousands of lives saved.”
More than 111,000 people with the virus have died in France.
Malaysia shuts vaccination center after 204 staff infected
Malaysia shut down a mass vaccination center in its worst-hit state Tuesday after more than 200 medical staff and volunteers tested positive for the coronavirus.
The closure was the first of a vaccination center and came as the country’s new confirmed infections breached five figures Tuesday, hitting a record 11,079.
Science Minister Khairy Jamaluddin stressed that swift government action had contained the cluster at the Ideal Convention Center in central Selangor state.
Khairy, who is in charge of the national immunization program, said he ordered the testing of all 453 workers at the center after two volunteers were confirmed to have the virus. Khairy said the 204 whose results were positive had low viral loads, meaning the amount of virus in their bodies was small.
Read:Immunized but banned: EU says not all COVID vaccines equal
This could be because 88% or 400 of the workers have already been vaccinated, he said.
The center was shut for deep sanitization and all its workers are being isolated. Khairy said it will reopen Wednesday with a new team of medical workers.
He urged people who were vaccinated at the center since Friday to isolate themselves for 10 days and be tested if they develop symptoms. He declined to say how many people had visited the center since Friday. It has the capacity to deliver up to 6,000 shots a day.
“This is the first time we had to shut down a (vaccination center) because of positive cases but we acted fast. By shutting it down today and by taking corrective measures ... we hope the disruption is only one day and that this will not hamper the vaccination process,” Khairy said.
Read: FDA adds warning about rare reaction to J&J COVID-19 vaccine
He said it would be safe to visit the center starting Wednesday for vaccinations.
Khairy said health measures at all other vaccination centers will be tightened, but didn’t order other workers to be tested.
Selangor, the country’s richest state bordering Kuala Lumpur, is the worst hit by the pandemic. It accounted for nearly half of Tuesday’s new cases, partly because of increased virus screening amid a tight lockdown.
The government has struggled to contain the pandemic, which has worsened despite a lockdown since June 1. Total confirmed cases have soared by 50% since June 1 to 855,949, while deaths have more than doubled to over 6,200.
Read: South Africa ramps up vaccine drive, too late for this surge
Hospitals especially in Selangor have been overwhelmed, with some patients reportedly being treated on the floor due to a lack of beds, and corpses piling up in mortuaries.
Vaccinations have picked up, with 11% of the population now fully inoculated. At least a quarter of the country’s 32 million people have received at least one dose of vaccine.
The daily vaccination rate surpassed 420,000 doses on Monday, the national Bernama news agency quoted Prime Minister Muhyiddin Yassin as saying,
He expressed confidence that the fast pace of vaccination would help stem the outbreak.
Nothing to be sceptical about Chinese vaccines: FM
Foreign Minister Dr AK Abdul Momen on Tuesday said there is nothing to worry about the safety of Chinese vaccines, mentioning that millions of people used the vaccines approved by the World Health Organization (WHO).
“Listen, we heard the same when Covid-19 vaccine – AstraZeneca – first came to Bangladesh. So, there’s nothing to worry about (Chinese vaccines). WHO approved the vaccines,” he said when a reporter raised the issue.
Dr Momen referred to what he saw in video (fake) that 13 nurses turned senseless in the UK after taking AstraZeneca vaccine doses. “This kind of thing comes up.”
More than 1 billion doses of Covid-19 vaccines have been administered in China, according to international media.
Read: FM reassures on adequate vaccine supply from multiple sources
“There has been no problem for any of them (in China) who got vaccinated,” said the Foreign Minister, adding that there is no reason to get worried.
Immunized but banned: EU says not all COVID vaccines equal
After Dr. Ifeanyi Nsofor and his wife received two doses of AstraZeneca’s coronavirus vaccine in Nigeria, they assumed they would be free to travel this summer to a European destination of their choice. They were wrong.
The couple — and millions of other people who have been vaccinated through a U.N.-backed effort — could find themselves barred from entering many European and other countries because those nations don’t recognize the Indian-made version of the vaccine for travel.
Although AstraZeneca vaccine produced in Europe has been authorized by the continent’s drug regulatory agency, the same shot manufactured in India hasn’t been given the green light.
EU regulators said AstraZeneca hasn’t completed the necessary paperwork on the Indian factory, including details on its production practices and quality control standards.
Read:FDA adds warning about rare reaction to J&J COVID-19 vaccine
But some experts describe the EU move as discriminatory and unscientific, pointing out that the World Health Organization has inspected and approved the factory. Health officials say the situation won’t only complicate travel and frustrate fragile economies but also undermine vaccine confidence by appearing to label some shots substandard.
As vaccination coverage rises across Europe and other rich countries, authorities anxious to salvage the summer tourism season are increasingly relaxing coronavirus border restrictions.
Earlier this month, the European Union introduced its digital COVID-19 certificate, which allows EU residents to move freely in the 27-nation bloc as long as they have been vaccinated with one of the four shots authorized by the European Medicines Agency, have a fresh negative test, or have proof they recently recovered from the virus.
While the U.S. and Britain remain largely closed to outside visitors, the EU certificate is seen as a potential model for travel in the COVID-19 era and a way to boost economies.
The officially EU-endorsed vaccines also include those made by Pfizer, Moderna and Johnson & Johnson. They don’t include the AstraZeneca shot made in India or many other vaccines used in developing countries, including those manufactured in China and Russia.
Individual EU countries are free to apply their own rules for travelers from inside and outside the bloc, and their rules vary widely, creating further confusion for tourists. Several EU countries, including Belgium, Germany and Switzerland, allow people to enter if they have had non-EU-endorsed vaccines; several others, including France and Italy, don’t.
For Nsofor, the realization he could be barred was “a rude awakening.” After a tough year of working during the pandemic in Abuja, Nsofor and his wife were looking forward to a European vacation with their two young daughters, perhaps admiring the Eiffel Tower in Paris or touring Salzburg in Austria.
Nsofor noted that the Indian-made vaccine he received had been authorized by WHO for emergency use and had been supplied through COVAX, the U.N.-backed program to provide shots to poor corners of the world. WHO’s approval included a visit to the Serum Institute of India factory to ensure that it had good manufacturing practices and that quality control standards were met.
“We’re grateful to the EU that they funded COVAX, but now they are essentially discriminating against a vaccine that they actively funded and promoted,” Nsofor said. “This will just give room to all kinds of conspiracy theories that the vaccines we’re getting in Africa are not as good as the ones they have for themselves in the West.”
Read: Pfizer to discuss vaccine booster with US officials Monday
Ivo Vlaev, a professor at Britain’s University of Warwick who advises the government on behavioral science during COVID-19, agreed that Western countries’ refusal to recognize vaccines used in poor countries could fuel mistrust.
“People who were already suspicious of vaccines will become even more suspicious,” Vlaev said. “They could also lose trust in public health messages from governments and be less willing to comply with COVID rules.”
Dr. Mesfin Teklu Tessema, director of health for the International Rescue Committee, said countries that have declined to recognize vaccines cleared by WHO are acting against the scientific evidence.
“Vaccines that have met WHO’s threshold should be accepted. Otherwise it looks like there’s an element of racism here,” he said.
WHO urged countries to recognize all of the vaccines it has authorized, including two Chinese-made ones. Countries that decline to do so are “undermining confidence in lifesaving vaccines that have already been shown to be safe and effective, affecting uptake of vaccines and potentially putting billions of people at risk,” the U.N. health agency said in a statement this month.
In June, the Serum Institute of India’s CEO, Adar Poonawalla, tweeted that he was concerned about vaccinated Indians facing problems traveling to the EU and said he was raising the problem at the highest levels with regulators and countries.
Stefan De Keersmaeker, a spokesman for the EU’s executive arm, said last week that regulators were obligated to check the production process at the Indian factory.
“We are not trying to create any doubts about this vaccine,” he said.
AstraZeneca said it only recently submitted the paperwork on the Indian factory to the EU drug regulatory agency. It didn’t say why it didn’t do so earlier, before the agency made its original decision in January.
Read: South Africa ramps up vaccine drive, too late for this surge
Public health experts warned that countries that decline to recognize vaccines backed by WHO are complicating global efforts to safely restart travel.
“You can’t just cut off countries from the rest of the world indefinitely,” said Dr. Raghib Ali of the University of Cambridge. “To exclude some people from certain countries because of the vaccine they’ve received is wholly inconsistent because we know that these approved vaccines are extremely protective.”
Nsofor said he and his wife are still deciding where to take their summer vacation and are leaning toward Singapore or East Africa.
“I didn’t realize there were so many layers to vaccine inequity,” he said.
Pfizer to discuss vaccine booster with US officials Monday
Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker’s request for federal authorization of a third dose of its COVID-19 vaccine as President Joe Biden’s chief medical adviser acknowledged that “it is entirely conceivable, maybe likely” that booster shots will be needed.
The company said it was scheduled to have the meeting with the Food and Drug Administration and other officials Monday, days after Pfizer asserted that booster shots would be needed within 12 months.
Pfizer’s Dr. Mikael Dolsten told The Associated Press last week that early data from the company’s booster study suggests people’s antibody levels jump five- to 10-fold after a third dose, compared to their second dose months earlier — evidence it believes supports the need for a booster.
Read:Pfizer to seek OK for 3rd vaccine dose; shots still protect
On Sunday, Dr. Anthony Fauci didn’t rule out the possibility but said it was too soon for the government to recommend another shot. He said the Centers for Disease Control and Prevention and the FDA did the right thing last week by pushing back against Pfizer’s assertion with their statement that they did not view booster shots as necessary “at this time.”
Fauci said clinical studies and laboratory data have yet to fully bear out the need for a booster to the current two-shot Pfizer and Moderna vaccines or the one-shot Johnson & Johnson regimen.
“Right now, given the data and the information we have, we do not need to give people a third shot,” he said. “That doesn’t mean we stop there. ... There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people.”
He said it was quite possible in the coming months “as data evolves” that the government may urge a booster based on such factors as age and underlying medical conditions. “Certainly it is entirely conceivable, maybe likely at some time, we will need a boost,″ Fauci said.
Read:AstraZeneca, Pfizer vaccines effective against Delta Covid-19 variants: Study
Monday’s planned meeting between Pfizer and U.S. health officials was first reported by The Washington Post.
Currently only about 48% of the U.S. population is fully vaccinated. Some parts of the country have far lower immunization rates, and in those places the delta variant is surging. Last week, Dr. Rochelle Walensky, the CDC director, said that’s leading to “two truths” — highly immunized swaths of America are getting back to normal while hospitalizations are rising in other places.
Fauci said it was inexplicable that some Americans are so resistant to getting a vaccine when scientific data show how effective it is in staving off COVID-19 infections and hospitalizations, and he was dismayed by efforts to block making vaccinations more accessible, such as Biden’s suggestion of door-to-door outreach.
Gov. Asa Hutchinson, R-Ark., agreed Sunday that there is a vaccine resistance in Southern and rural states like his because “you have that more conservative approach, skepticism about government.”
Read:AP source: US to buy 500M Pfizer vaccines to share globally
Describing his efforts to boost vaccinations in his state, which is seeing rising infections, Hutchinson said “no one wants an agent knocking on a door,” but “we do want those that do not have access otherwise to make sure they know about it.”
The grassroots component of the federal vaccination campaign has been in operation since April, when supplies of shots began outpacing demand. It was outlined and funded by Congress in the $1.9 trillion COVID-19 relief bill passed in March and overwhelmingly is carried out by local officials and private sector workers and volunteers.
Rep. Adam Kinzinger, R-Ill., blasted opposition to vaccination efforts from some GOP lawmakers as “absolute insanity.” He said House Republican leader Kevin McCarthy of California and others in the party need to speak out against “these absolute clown politicians playing on your vaccine fears for their own selfish gain.”
Fauci appeared on CNN’s “State of the Union,” ABC’s “This Week” and CBS’ “Face the Nation”; Hutchinson spoke on ABC, and Kinzinger was on CNN.
Mass inoculation to restart Monday with Sinopharm, Tuesday with Moderna: DGHS
Mass inoculation for Covid-19 will restart from Monday (July 12) with Chinese vaccine Sinopharm in district and upazila hospitals and from Tuesday (July 13) with COVAX’s Modera jabs in municipal hospitals, said the Directorate General of Health Services (DGHS) Sunday.
Line director of the vaccine deployment committee, Professor Dr Shamsul Haque announced the news during the regular Covid-19 bulletin of the DGHS.
By Sunday Moderna doses will reach vaccine centres across the country, while Sinopharm doses were sent Saturday to all the municipal centres, he said.
Also read: Massive vaccination to begin in July: PM
The additional stock has been ensured for sending to districts and upazilas, said Dr Shamsul Haque, mentioning that all the preparation for mass inoculation has been completed.
As from Monday and the next day, people across the country will start getting shots again, it can be said that mass inoculation for Covi-19 resumed, he added.
Dr Haque said the 1 lakh doses of Pfizer vaccine so far received will be administered at the seven hospitals of Dhaka and after that Moderna vaccine doses will be administered in these hospitals.
Also read: Registration for Covid vaccination to restart Thursday
In the other 40 Covid-19 vaccination centres of the city, Sinopharm vaccine shots will be administered till Monday and after that Moderna shots will be administered in those hospitals, he added.
Soon a decision will be taken on the urgent vaccination needs of the students who want to go abroad for study as a conversation with the Prime Minister is ongoing, said the line director of the vaccine deployment committee.
Until now expatriate workers were being vaccinated in seven centres of Dhaka, but from Monday they will be able to receive the shots from any medical college of the country, said Dr Shamsul.